Yonsei Med J.
2023 May;64(5):349-349. 10.3349/ymj.2003.0386.re.
Paper “Efficacy of Oral Etidronate for Skeletal Diseases in Japan” by Iwamoto J, et al. [Yonsei Med J 2005 Jun;46(3):313-320]
- KMID: 2541815
- DOI: http://doi.org/10.3349/ymj.2003.0386.re
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Retraction: Paper “Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis†by Iwamoto J, et al. [Yonsei Med J 2005;46(6):750-758]
- Efficacy of Oral Etidronate for Skeletal Diseases in Japan
- Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]
- Retraction: Paper “Comparison of the Effect of Vitamin K2 and Risedronate on Trabecular Bone in Glucocorticoid-Treated Rats: A Bone Histomorphometry Study†by Iwamoto J, et al. [Yonsei Med J 2009;50(2):189-194]
- Retraction: Paper “Combined Treatment with Vitamin K₂ and Bisphosphonate in Postmenopausal Women with Osteoporosis†by Iwamoto J, et al. [Yonsei Med J 2003;44(5):751-756]
